SARI - Publikationen


Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P.
Increasing consumption of MRSA-active drugs without increasing MRSA in German ICUs.
Intensive Care Med. 2011 DOI: 10.1007/s00134-011-2335-9

Meyer E, Gastmeier P.
Können wir Transmissionen von multiresistenten Erregern auf der Intensivstation verhindern?
Intensiv-News 2011; 15(3): 6-7

Meyer E, Ziegler R, Mattner F, Schwab F, Gastmeier P, Martin M.
Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum ß-lactamase-producing Enterobacteriaceae.
Infection. 2011 Jun 28. [Epub ahead of print]

Meyer E, Schwab F, Gastmeier P.
Nosocomial Methicillin resistant Staphylococcus aureus Pneumonia – Epidemiology and Trends based on Data of a Network of 586 German ICUs (2005-2009).
Eur J Med Res 2010; 15(12): 514-524

Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P.
Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
Crit Care. 2010; 14;14(3):R113.

Meyer E, Schwab F, Pollitt A, Bettolo W, Schroeren-Boersch B, Trautmann M.
Impact of a Change in Antibiotic Prophylaxis on Total Antibiotic Use in a Surgical Intensive Care Unit.
Infection. 2010;38(1):19-24

Meyer E, Schwab F, Schroeren-Boersch B, Rüden H, Gastmeier P.
Diversität des Antibiotikaverbrauchs auf Intensivstationen in Deutschland.
Dtsch Med Wochenschr 133(6):235-40; 2008

Jonas D, Meyer E, Schwab F, Grundmann H.
Genodiversity of Resistant Pseudomonas aeruginosa Isolates in Relation to Antimicrobial Usage Density and Resistance Rates in Intensive Care Units.
Infect Control Hosp Epidemiol 29(4):350-7; 2008

Meyer E, Lunke C, Kist M, Schwab F, Frank U
Antimicrobial resistance in Escherichia coli strains Infection strains isolated from food, animals and humans in Germany.
Infection 36(1):59-61; 2008

Meyer E, Schwab F, Gastmeier P
Use of very old and very new antibiotics in Intensive Care Units in Germany.
Journal of Antimicrobial Chemotherapy 60(6):1413-1415; 2007

Meyer E, Schwab F, Gastmeier P, Rueden H, Heininger A
Antifungal use in intensive care units.
Journal of Antimicrobial Chemotherapy 60(3): 619-624; 2007

Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, Rueden H, Zentner J, Daschner FD, Schwab F
Modified guidelines impact on antibiotic use and costs. Duration of treatment for pneumonia in a neurosurgical ICU is reduced.
Journal of Antimicrobial Chemotherapy 59(6): 1148-1154; 2007

Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, Gastmeier P, Ruden H, Zentner J, Daschner FD, Schwab F
Modified guidelines impact on antibiotic use and costs. Duration of treatment for pneumonia in a neurosurgical ICU is reduced. Journal of Antimicrobial Chemotherapy (in press)

Meyer E, Gastmeier P
Antibiotikatherapie – Einfluss und Methodik der Surveillance. AINS 2: 116-121; 2007-02-18

Meyer E, Schwab F, Pollitt A, Trautmann M
Resistance rates in ICUs: interpretation and pitfalls. J Hosp Infect. 65 (1): 85-84; 2007

Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD
Surveillance of antimicrobial use and antimicrobial resistance in German Intensive Care Units (SARI) – A summary of the data from 2001 through 2004. Infection 34(6): 303-309; 2006

Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD
Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units? Eur J Clin Microbiol Infect Dis. 25(11), 711-714; 2006

Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD, Jonas D
Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). J Hosp Infect. 64(3), 238-43; 2006

Heininger A, Meyer E, Schwab F, Marschal M, Unertl K, Krueger WA
Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Med. 32(10), 1569-76, 2006

Meyer E, Schwab F, Jonas D, Gastmeier P, Rueden H, Daschner FD:
Methicillin resistant Staphyloccocus aureus in German Intensive Care Units (2000-2003). Data from the project Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units (SARI). Infect. Control. Hosp. Epidemiol. 27, 146-154, 2006

de With K, Meyer E, Steib-Bauert M, Schwab F, Daschner FD, Kern WV.
Antibiotic use in two cohorts of German intensive care units. J Hosp Infect. 64(3):231-7, 2006

Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner FD
Temporal changes in bacterial resistance in German Intensive Care Units, 2001 -2003. Data from project SARI. (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). J. Hosp. Infect. 60, 348-352, 2005

Meyer E, Ebner W, Heininger A, Schwab F, Rüden H, Daschner FD
Mikrobiologische Diagnostik und Antibiotikamangement von ambulant und nosokomial erworbenen Pneumonien auf Intensivstationen in Deutschland. AINS 40(2), 85-90, 2005

Meyer E, Trittler R
Surveillance of Antibiotic Use in German ICUs. Hosp. Pharm. Eur. 19, 81-82, 2005

Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD
SARI: Surveillance der Antibiotikaanwendung und der bakteriellen Resistenzentwicklung auf deutschen Intensivstationen. Zu den Zusammenhängen von Antibiotikaverbrauch und Resistenzsituation. Bundesgesundheitsblatt 47, 345-351, 2004

Gastmeier P, Meyer E, Schwab F, Geffers C, Rüden H, Daschner FD
KISS und SARI: Benchmarking und Referenzdaten für Krankenhausinfektionen, Antibiotika-Verbrauch und Resistenz auf deutschen Intensivstationen. Intensivmed 41, 133-138, 2004

de With K, Schroder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kammerer R, Ruess S, Daschner FD, Kern WV
Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr 129(38), 1987-1992, 2004

Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner FD
Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med. 30, 1089-1096, 2004

Jonas D, Biehler K, Hartung D, Spitzmuller B, Daschner FD
Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.
Antimicrob Agents Chemother. 2005 Feb;49(2):773-5.

Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.
J Clin Microbiol. 2004 Dec;42(12):5644-9.

Meyer E, Schroeren-Boersch B, Schwab F, Jonas D, Ruden H, Gastmeier P, Daschner FD
Quality assurance in intensive care medicine SARI-Surveillance on antibiotic use and bacterial resistance in intensive care units
Anaesthesist. 2004; 53 (5): 427-433

Meyer E, Schwab F, Jonas D, Rueden H, Gastmeier P, Daschner FD
Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units.
Intensive Care Med. 2004; 30 (6): 1089-1096

Gastmeier P, Chaberny I, Sohr D, Schwab F, Meyer E, Daschner FD, Rüden H
Welche Indikatoren eignen sich zur Beurteilung der MRSA-Situation?
Klinikarzt 2004; 33 (1+2): 10–14

Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD
SARI: Surveillance der Antibiotikaanwendung und der bakteriellen Resistenzentwicklung auf deutschen Intensivstationen. Zu den Zusammenhängen von Antibiotikaverbrauch und Resistenzsituation
Bundesgesundheitsblatt 2004; 47: 345-351

Meyer E, Jonas D, F. Schwab F, Rueden H, Gastmeier P, Daschner FD
Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI).
Infection (2003) 31:208-215

Jonas D, Spitzmüller B, Daschner FD, Verhoef J, Brisse S
Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Res. Microbiol. 155, 17-23, 2004

Jonas D, Spitzmüller B, Weist K, Rüden H, Daschner FD
Comparison of PCR-based methods for typing Escherichia coli.
Clinical Microbiology and Infection 9, 823-831, 2003

Zum Antibiotikaverbrauch und zu bakteriellen Resistenzen auf Intensivstationen.
Aktuelle Daten des Projektes SARI – Stand September 2003
Epid Bull 18, 2003, 140-141